Andrew S. Wellin


Andrew S. Wellin’s antitrust practice includes regulatory counseling on mergers and acquisitions before federal, state, and international competition authorities as well as private antitrust litigation in the federal and state courts. Drew also has extensive experience counseling clients on the antitrust risk arising from settlement agreements between pioneer and generic pharmaceutical manufacturers involved in Hatch-Waxman Act patent infringement litigation.